Browse All

Current Filters

CLEAR FILTER x

TITLE

Multiple Sclerosis Disease Activity is Uncommon in Individuals With Pre-existing Multiple Sclerosis Exposed to Immune Checkpoint Inhibitor Therapy

Author:Gill, Alexander   Krett, Jonathan   Quinn, Carson   Rajarajan, Prashanth   Babcock, Lyndsey   Kaiser, Anna   Morrison, Andrew   Pisano, Thomas   Paracha, Atika   Dodson, Cory   Kopinsky, Hannah   Moninuola, Iwalewa   Alhassan, Said   Stewart, Wendy   Aguilera-Pena, Maria   Ramierz Guerrero, Sofia   Modak, Nikhil   Jean, Maxime   Lamb, Jessica   Piura, Yoav   CARRIER, Jordan   Arvas, Muhammed Ikbal   Camargo, Celeste   Bhise, Vikram   Linnoila, Jenny   Chaudhry, Vinay   Bhattacharyya, Shamik   Alvarez, Enrique   Kantor, Daniel   Nelsion, Flavia   Rammohan, Kottil   Coyle, Patricia   Hemminger, Lauryn   Baldwin, Nicole   Hutton, George   Simpson, Alexandra   Barreras, Paula   Dujmovic Basuroski, Irena   Harrington, Cole   Douglas, Anne   Day, Gregory   Kister, Ilya   Galetta, Kristin   Conway, Sarah   Roy, Shuvro   Gadani, Sachin   Wolf, Andrew   Probasco, John   

Session Name:P4: Multiple Sclerosis: Clinical Science 1  

Topic:Multiple Sclerosis  

Program Number:P4.002  

Author Institution:Autoimmune Neurology Research Consortium (ANRC), Somerville, MA  Johns Hopkins School of Medicine, Calgary, AB, Canada  Mass General Brigham, Boston, MA  University of Colorado School of Medicine, Morrison, CO  University of Pittsburgh, Pittsburgh, PA  Hospital of the University of Pennsylvania, Philadelphia, PA  University of Washington, Madison, NJ  Stanford University, PALO ALTO, CA  New York University Grossman School of Medicine, NY  The Ohio State University Wexner Medical Center, OH  University of North Carolina School of Medicine, NC  University of Virginia School of Medicine, VA  Cedars-Sinai Medical Center, CA  University of Rochester, Rochester, NY  Stony Brook Medicine, NY  Mayo Clinic, Jacksonville, FL  Baylor College of Medicine, Houston, TX  Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ  Medical Partnership 4 MS+, Coconut Creek, FL  University of Miami, FL  Stony Brook Medicine, Stony Brook, NY  

Pediatrician Involvement in Communicating Positive Newborn Screening Results for Krabbe Disease: Barriers, Facilitators, and Ideas for Interventions

The Evolution of Randomized Clinical Trial Designs to Assess Therapeutics in Alzheimer Disease

Author:Arfaie, Saman   Aumont, Etienne   Therriault, Joseph   Kwan, Angela   Carello-Collar, Giovanna   Hall, Brandon   Ferrari-Souza, João-Pedro   Woo, Marcel   Macedo, Arthur   Tissot, Cécile   Trudel, Lydia   Rahmouni, Nesrine   Servaes, Stijn   Vitali, Paolo   Soucy, Jean-Paul   Pascoal, Tharick   Zimmer, Eduardo   Gauthier, Serge   Rosa Neto, Pedro   

Session Name:P4: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 2  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P4.012  

Author Institution:McGill University Research Centre for Studies in Aging, Montréal, QC, Canada  McGill University Research Centre for Studies in Aging, QC, Canada  McGill University Research Centre for Studies in Aging, Ottawa, ON, Canada  Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, , Brazil  6Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, Germany  Lawrence Berkeley National Laboratory, University of California, Berkeley, CA  McGill University Research Centre for Studies in Aging, Montreal, QC, Canada  University of Pittsburgh, Pittsburgh, PA  Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil, PORTO ALEGRE, Brazil  Douglas Hospital, Verdun, QC, Canada